Deliver a New Level of Care

Make more informed clinical decisions — and support population health — with one connected chronic care platform for multiple cardiometabolic conditions and comorbidities.

Discover between-visit chronic care.
GettyImages 1199215126 1
Group 427319249

One connected chronic care hub that integrates seamlessly into existing clinical systems and workflows

Welldoc is differentiated by clinical rigor and industry recognition

9
510(k) FDA-Clearances for BlueStar®*
60+
Clinical Publications
31
Patents
*Welldoc Diabetes Rx/OTC is an FDA-cleared medical device (“BlueStar”), intended for use by healthcare providers and their adult patients with type 1 or type 2 diabetes. For full labeling information, visitwww.welldoc.com. The other Welldoc products are non-FDA-cleared and intended to promote general wellness and education/self-management of various chronic disease states.

Coordinated, data-driven chronic care — between office visits

The Welldoc platform provides much more than a vehicle for recording patient health data. Our advanced AI keeps patients engaged with personalized, real-time digital coaching — giving care teams enhanced visibility into patient health through data, insights, and reporting.
Our data-driven approach enables your care teams to make more timely, informed clinical decisions, helping to optimize patient and care team communication -and interactions- while supporting chronic care populations.

The Welldoc Platform supports population health by providing care teams with enhanced health data and analytics on individuals and groups — helping organizations reduce redundancies, close care gaps, and more effectively coordinate data and care.

Welldoc seamlessly integrates real-time, actionable, patient-generated data (e.g., weight, blood pressure and blood glucose patterns) into existing clinical workflows, enabling your care teams to draw connections and deep learning with pattern-based insights and reporting.

The Welldoc Platform supports population health by providing care teams with enhanced health data and analytics on individuals and groups — helping organizations reduce redundancies, close care gaps, and more effectively coordinate data and care.

Chronic conditions account for up to 75% of all healthcare costs.1

Consistent engagement supports better self-management and health outcomes

The Welldoc Platform gives care teams more time to focus on what they do best, while patient lives are enhanced, and clinical outcomes are improved.
Group 509
Patient engagement of 30x/ week on average.2
Group 39
A 1.2 to 2.0-point average A1C reduction in individuals living with type 2 diabetes3,4
Group 508
7.2 – 12 mmHg drop in blood pressure in the first 3 months of use5

Cost Optimization

$3048-$3252 per person with type 2 diabetes, annually6
While we address multiple conditions and comorbidities, our results can be correlated with cost reductions in three primary areas:
1) Cost of hospitalizations, ER visits, and HCP office visits
2) Cost of devices, supplies, and medications
3) Cost of co-morbid
complications

Learn how Welldoc can help you improve chronic care

*Welldoc Diabetes Rx/OTC is an FDA-cleared medical device (“BlueStar”), intended for use by healthcare providers and their adult patients with type 1 or type 2 diabetes. For full labeling information, visit www.welldoc.com. The other Welldoc products are non-FDA-cleared and intended to promote general wellness and education/self-management of various chronic disease states.

References:
1 Norbeck TB. Drivers of Health Care Costs. Missouri Medicine. 2013;110(2):113-118. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179664/
2 Snow, K. Iyer, A. Shearer, D. Peeples, M. Interactive Digital Health: Engaging Health Behaviors & Clinical Outcomes. Poster presented at: ADCES 2020 Virtual Conference, August 2020.
3 Tang PY, Duni J, Peeples MM, et al. Complementarity of digital health and peer support: “This Is What’s Coming.” Front Clin Diabetes Health. 2021;2. doi:10.3389/fcdhc.2021.646963
4 Quinn CC, Sareh PL, Shardell ML, Terrin ML, Barr EA, Gruber-Baldini AL. Mobile Diabetes Intervention for Glycemic Control. Journal of Diabetes Science and Technology. 2014;8(2):362-370. doi:10.1177/1932296813514503
5 Kumbara A, Iyer A, Shomali M. Blood pressure improvement in people using a digital health solution for comprehensive diabetes self-management. Poster presented at: 16th Annual Cardiometabolic Health Congress; October 14-17, 2021; National Harbor, MD.
6 IBM Watson Health. Estimating the economic value of a digital therapeutic in type 2 diabetes. Welldoc sponsored report 2018. Published August 2018.
small_c_popup.png

Taking Diabetes Self-Management to the Next Level